Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for HRMY stock have an average target of 52.88, with a low estimate of 40 and a high estimate of 70. The average target predicts an increase of 55.28% from the current stock price of 34.06.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$40	$52.88	$55	$70
Change	+17.46%	+55.28%	+61.50%	+105.55%

Analyst Ratings

The average analyst rating for HRMY stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	4	4	4	4	4	4
Buy	4	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	1	0	0	0	0	0
Strong Sell	1	0	0	0	0	0
Total	10	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ami Fadia Needham	Needham	Strong Buy Reiterates $49	Strong Buy	Reiterates	$49	+43.88%	May 7, 2025
Ami Fadia Needham	Needham	Strong Buy Reiterates $49	Strong Buy	Reiterates	$49	+43.88%	May 6, 2025
Ashwani Verma UBS	UBS	Strong Buy Maintains $55 → $48	Strong Buy	Maintains	$55 → $48	+40.95%	Apr 28, 2025
Ami Fadia Needham	Needham	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+46.82%	Apr 10, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $70	Strong Buy	Reiterates	$70	+105.55%	Apr 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

858.12M

Increased by 20.06%

from 714.73M

Revenue Next Year

1.02B

Increased by 18.40%

from 858.12M

EPS This Year

3.14

Increased by 25.16%

from 2.51

EPS Next Year

4.28

Increased by 36.36%

from 3.14

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	159.74M	305.44M	437.86M	582.02M	714.73M	858.12M	1.02B	1.23B
Revenue Growth	2,564.59%	91.21%	43.35%	32.93%	22.80%	20.06%	18.40%	20.57%
EPS	-2.48	0.58	2.97	2.13	2.51	3.14	4.28	5.72
EPS Growth	-	-	412.07%	-28.28%	17.84%	25.16%	36.36%	33.63%
Forward PE	-	-	-	-	-	10.84	7.95	5.95
No. Analysts	-	-	-	-	-	11	10	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	902.6M	1.1B	1.4B
Avg	858.1M	1.0B	1.2B
Low	803.5M	915.1M	1.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	26.3%	28.3%	38.1%
Avg	20.1%	18.4%	20.6%
Low	12.4%	6.6%	-0.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	4.22	5.25	7.88
Avg	3.14	4.28	5.72
Low	1.62	2.77	4.44

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	68.2%	67.1%	83.8%
Avg	25.2%	36.4%	33.6%
Low	-35.6%	-11.7%	3.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.